Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening

scientific article

Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JM030504I
P8608Fatcat IDrelease_qgwh6ka6r5afnfd4am47zkpup4
P698PubMed publication ID15055996

P2093author name stringPaul D Lyne
Sonya Zabludoff
Susan Ashwell
Chun Deng
David A Cosgrove
Peter W Kenny
John J Wendoloski
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)1962-1968
P577publication date2004-04-01
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleIdentification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening
P478volume47

Reverse relations

cites work (P2860)
Q44823868Automated molecule editing in molecular design
Q56916101Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR
Q27998704Combining docking with pharmacophore filtering for improved virtual screening
Q36477542Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach
Q31139520Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening
Q56979637Designing a ligand for pharmaceutical purposes
Q27659340Discovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual Screening
Q54346146Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
Q36477457Finding protein kinase hits using structural information
Q36117828First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.
Q33616659Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening
Q24656051Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach
Q49959079Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation.
Q54577952Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation.
Q36654909New approaches to molecular cancer therapeutics
Q36939959Novel inhibitors of checkpoint kinase 1.
Q36549367PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness
Q40007226Pharmacophore modelling and synthesis of quinoline-3-carbohydrazide as antioxidants
Q38028528Pharmacophore-based virtual screening: a review of recent applications
Q36266998Reengineering the pharmaceutical industry by crash-testing molecules
Q27649874Rescoring Docking Hit Lists for Model Cavity Sites: Predictions and Experimental Testing
Q35229529Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor
Q33270545Scoring functions and enrichment: a case study on Hsp90.
Q33238328Structure-based development of target-specific compound libraries
Q33271049Ultrafast de novo docking combining pharmacophores and combinatorics
Q51714832Using protein-ligand docking to assess the chemical tractability of inhibiting a protein target.
Q34626368Virtual screening of chemical libraries for drug discovery
Q39998714Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).

Search more.